These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8671808

  • 1. Treatment of hyperparathyroidism--why is it crucial to control serum phosphate?
    Brancaccio D, Gallieni M, Cozzolino M.
    Nephrol Dial Transplant; 1996 Mar; 11(3):420-3. PubMed ID: 8671808
    [No Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Current treatment options in secondary renal hyperparathyroidism.
    Bonne JF, Mansour J, Moriniere P, Shahapuni I, Fournier A.
    Nephrol Dial Transplant; 2006 Oct; 21(10):2987-9; author reply 2989-90. PubMed ID: 16935909
    [No Abstract] [Full Text] [Related]

  • 7. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N, Amor J, Cambil T, Salgueira M, Sánchez-Palencia R, Páez C, Gómez O, Palma A.
    Nefrologia; 2003 Oct; 23 Suppl 2():64-8. PubMed ID: 12778857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone.
    Elder G, Faull R, Branley P, Hawley C, Caring for Australasians with Renal Impairment (CARI).
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S230-61. PubMed ID: 16684078
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M.
    Nefrologia; 2002 Apr; 22(5):448-55. PubMed ID: 12497746
    [Abstract] [Full Text] [Related]

  • 14. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Apr; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 15. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.
    Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M.
    J Nephrol; 2007 Dec; 20(1):3-9. PubMed ID: 17347966
    [Abstract] [Full Text] [Related]

  • 18. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P.
    Semin Dial; 2009 Dec; 22(3):242-4. PubMed ID: 19572999
    [No Abstract] [Full Text] [Related]

  • 19. Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.
    Hudson JQ.
    Ann Pharmacother; 2006 Sep; 40(9):1584-93. PubMed ID: 16912241
    [Abstract] [Full Text] [Related]

  • 20. Medical treatment in primary and secondary hyperparathyroidism.
    Coburn JW, Brickman AS, Massry SG.
    Semin Drug Treat; 1972 Sep; 2(1):117-35. PubMed ID: 4261783
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.